SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-091303
Filing Date
2022-08-15
Accepted
2022-08-15 17:56:02
Documents
4
Period of Report
2022-09-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2222663-2_def14a.htm DEF 14A 880446
2 GRAPHIC lg_kioraparma-bwlr.jpg GRAPHIC 20004
3 GRAPHIC tm2222663d1-px_page01bw.jpg GRAPHIC 1253153
4 GRAPHIC tm2222663d1-px_page02bw.jpg GRAPHIC 643028
  Complete submission text file 0001104659-22-091303.txt   3516982
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36672 | Film No.: 221167270
SIC: 2834 Pharmaceutical Preparations